Avidity Biosciences
RNA
#1870
Rank
C$15.39 B
Marketcap
C$99.63
Share price
0.00%
Change (1 day)
125.27%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$15.39 Billion

As of February 2026 Avidity Biosciences has a market cap of C$15.39 Billion. This makes Avidity Biosciences the world's 1870th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026C$15.39 B3.41%
2025C$14.88 B188.72%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Feb 21st, 2026 the market cap of Avidity Biosciences was reported to be:

C$15.01 Billion
by Nasdaq info icon info icon
C$15.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$207.19 B 1,246.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$163.31 B 961.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.70 B-82.42%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$7.75 B-49.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.23 B-98.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$14.94 B-2.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.08 B-73.46%๐Ÿ‡บ๐Ÿ‡ธ USA